ASH Press Briefing 1, Saturday December 9, 2023
ASH Press Briefing 1, Saturday December 9, 2023
.
-
Abstract 901 Interpretable Artificial Intelligence (AI) Differentiates Prefibrotic Primary Myelofibrosis (prePMF) from Essential Thrombocythemia (ET): A Multi-Center Study of a New Clinical Decision Support Tool
-
Abstract 1057 Understanding the Experiences of Patients with Sickle Cell Disease and Their Caregivers By Social Media Listening in the UK
-
Abstract 157 An Entirely Oral Regimen of Oral-Arsenic Trioxide/All-Trans Retinoic Acid/Ascorbic Acid in Newly-Diagnosed Acute Promyelocytic Leukaemia (APL): Updated Results of an Ongoing Multicentre Trial
-
Abstract 220 CD19-Targeted CAR-T Cells in Refractory Systemic Autoimmune Diseases: A Monocentric Experience from the First Fifteen Patients
Abstract 901 Interpretable Artificial Intelligence (AI) Differentiates Prefibrotic Primary Myelofibrosis (prePMF) from Essential Thrombocythemia (ET)
Das Laden von Vimeo wurde nicht erlaubt. Bitte ändern Sie die Datenschutz-Einstellungen
Abstract 1057 Understanding the Experiences of Patients with Sickle Cell Disease and Their Caregivers By Social Media Listening in the UK
Das Laden von Vimeo wurde nicht erlaubt. Bitte ändern Sie die Datenschutz-Einstellungen
Abstract 157 An Entirely Oral Regimen of Oral-Arsenic Trioxide/All-Trans Retinoic Acid/Ascorbic Acid in Newly-Diagnosed Acute Promyelocytic Leukaemia (APL)
Das Laden von Vimeo wurde nicht erlaubt. Bitte ändern Sie die Datenschutz-Einstellungen
Abstract 220 CD19-Targeted CAR-T Cells in Refractory Systemic Autoimmune Diseases: A Monocentric Experience from the First Fifteen Patients
Das Laden von Vimeo wurde nicht erlaubt. Bitte ändern Sie die Datenschutz-Einstellungen
Copyright 2025. All Rights Reserved.
You are using an outdated browser. The website may not be displayed correctly. Close